FIELD: medicine, in particular experimental biology.
SUBSTANCE: invention relates to method for prophylaxis and treatment of systemic amyloidosis and nephropathic form thereof, induced in experimental animal. In this purpose 10 % mildronate solution is hypodermically administrated to animals every second day in dose of 50 mg/kg during last 14 days of experiment.
EFFECT: effective method for disease treatment due to simultaneous action on different component of pathogenesis, namely amyloid mass formation in kidney.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREVENTING SYSTEMIC AMYLOIDOSIS AND ITS NEPHROPATIC FORM IN EXPERIMENTAL ANIMALS | 2009 |
|
RU2410764C1 |
| METHOD FOR PREVENTION OF SYSTEMIC AMYLOIDOSIS AND ITS NEPHROPATHIC FORM IN EXPERIMENTAL ANIMALS | 2011 |
|
RU2473134C2 |
| METHOD FOR PREVENTION OF SYSTEMIC AMYLOIDOSIS AND ITS NEPHROPATIC FORM IN EXPERIMENTAL ANIMALS | 2008 |
|
RU2381797C1 |
| METHOD FOR PREVENTION OF SYSTEMIC AMYLOIDOSIS AND ITS NEPHROPATHIC CONDITION IN EXPERIMENTAL ANIMALS | 2008 |
|
RU2386415C1 |
| METHOD FOR PREVENTION OF SYSTEMIC AMYLOIDOSIS AND ITS NEPHROPATHIC FORM IN EXPERIMENTAL ANIMALS | 2011 |
|
RU2473133C2 |
| METHOD FOR MODELING EXPERIMENTAL AMYLOIDOSIS IN ANIMALS | 2004 |
|
RU2269825C1 |
| METHOD FOR SIMULATING GENERALISED AMYLOIDOSIS IN ANIMALS | 2013 |
|
RU2536556C2 |
| METHOD FOR SIMULATION OF EXPERIMENTAL AMYLOIDOSIS IN ANIMALS | 2010 |
|
RU2446482C1 |
| METHOD OF MODELLING EXPERIMENTAL AMYLOIDOSIS IN RATS | 2009 |
|
RU2410761C1 |
| METHOD OF SIMULATING AMYLOIDOSIS IN ANIMALS | 2008 |
|
RU2373581C1 |
